Previous Article | Next Article 
Journal of Clinical Microbiology, April 2001, p. 1467-1476, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1467-1476.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Tsukamurella strandjordae sp. nov., a
Proposed New Species Causing Sepsis
Mireille M.
Kattar,1
Brad T.
Cookson,1,2
LaDonna C.
Carlson,1
Susan K.
Stiglich,1
Margot A.
Schwartz,3
Trang T.
Nguyen,1
Riza
Daza,1
Carolyn K.
Wallis,1
Stuart L.
Yarfitz,4 and
Marie B.
Coyle1,2,*
Departments of Laboratory
Medicine,1
Microbiology,2 and
Medicine,3 Division of
Infectious Disease, and Department of Medical Education, Division of
Bioinformatics,4 University of Washington,
Seattle, Washington
Received 12 July 2000/Returned for modification 23 October
2000/Accepted 28 January 2001
 |
ABSTRACT |
We have isolated a gram-positive, weakly acid-alcohol-fast,
irregular rod-shaped bacterium from cultures of blood from a 5-year-old girl with acute myelogenous leukemia. This isolate was compared with 14 other strains including reference strains of Tsukamurella species by a polyphasic approach based on physiological and biochemical properties, whole-cell short-chain fatty acid and mycolic acid analyses, DNA-DNA hybridization, and sequencing of the 16S rRNA gene.
This isolate represents a new taxon within the genus
Tsukamurella for which we propose the name
Tsukamurella strandjordae sp. nov. Our study also revealed
that Tsukamurella paurometabola ATCC 25938 represents a
misnamed Tsukamurella inchonensis isolate and confirms that
Tsukamurella wratislaviensis belongs to the genus
Rhodococcus.
 |
INTRODUCTION |
Tsukamurellae are members of the
mycolic acid-containing aerobic actinomycetes. The genus was created in
1988 to accommodate a group of chemically unique organisms
characterized by a series of very long chain (68 to 76 carbons) highly
unsaturated (two to six double bonds) mycolic acids, in addition to
possessing meso-diaminopimelic acid and arabinogalactan,
common to the genus Corynebacterium (6). The
type species, Tsukamurella paurometabola, described by
Steinhaus as Corynebacterium paurometabolum in 1941, was
originally isolated from the mycetomes and ovaries of bed bugs
(27). The first human isolate of Tsukamurella
was reported in 1971 as Gordona aurantiaca
(33). Four additional species were proposed in the 1990s.
Tsukamurella wratislaviensis was isolated from soil
(10). Strains of Tsukamurella inchonensis,
Tsukamurella pulmonis, and Tsukamurella tyrosinosolvens
have been isolated only from human specimens, and all were associated
with clinical disease (34-36). We have encountered an
unusual isolate in multiple cultures of blood from a 5-year-old girl
with acute myelogenous leukemia who presented with sepsis. On the basis
of physiological and biochemical characteristics, analysis of cell
components, DNA-DNA hybridizations, and the 16S rRNA gene sequence, we
propose that this strain represents a new taxon within the genus
Tsukamurella to which we assign the name Tsukamurella
strandjordae sp. nov. Our study compared this isolate to reference
and clinical strains of the other Tsukamurella species and
found that T. paurometabola ATCC 25938 is a misnamed
T. inchonensis isolate.
 |
MATERIAL AND METHODS |
Strains.
The study included type strains of all proposed
Tsukamurella species. T. paurometabola ATCC 8368 and T. wratislaviensis ATCC 51786 were purchased from the
American Type Culture Collection (ATCC). A. F. Yassin generously
provided the type strains T. pulmonis ATCC 700081 and
T. inchonesis ATCC 700082. Type strain T. tyrosinosolvens DSMZ 44234 was purchased from the Deutsche
Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ; Braunschweig,
Germany). Other purchased reference strains included strains T. paurometabola ATCC 25938 and T. tyrosinosolvens DSMZ
44316. The strain of T. strandjordae, the subject of this
study, was isolated from a 5-year-old girl with acute myelogenous
leukemia who presented with sepsis. T. strandjordae was the
sole bacterial isolate in four consecutive blood samples for culture
drawn over 1-week period. All broth cultures became positive within
24 h (BACTEC 9240 with Peds PLUS medium; Becton Dickinson, Sparks,
Md.). Isolates from all four cultures were analyzed. A detailed
clinical history has been published elsewhere (4). In
addition, we analyzed seven clinical isolates of other
Tsukamurella species, including three T. pulmonis, two T. inchonensis, and two T. tyrosinosolvens isolates that were referred to our laboratory for
identification between 1993 and 2000. Species-level identification of
the clinical isolates was achieved by the polyphasic approach outlined below.
Media and morphology.
Routine mycobacterial identification
tests were inoculated with growth from Middlebrook 7H11 agar (Remel,
Lenexa, Kans.). Temperature response studies were done on
Lowenstein-Jensen slants (Remel) and read after 1 week. The urease test
was performed by the Murphy Hawkins disk method (BBL, Cockeysville,
Md.). The lysozyme test was performed with lysozyme broth and included
a glycerol broth control (Remel). For analyses by gas-liquid
chromatography (GLC) with the Microbial Identification System (MIS;
MIDI, Newark, Del.) by the mycobacteriological method and for
high-performance liquid chromatography (HPLC) analysis, cells were
grown on Middlebrook 7H11 agar (Remel). For analysis by the MIDI
clinical method, all nonmycobacterial biochemical tests, and evaluation
of gross colonial morphology, cells were grown on Trypticase soy agar
supplemented with 5% sheep blood (TSA; Remel). For inoculation into
API 50 CH strips (see below), cells were grown on nutrient agar
(Remel). To assess colonial micromorphology, cells were grown on tap
water agar. Air-dried smears, obtained from growth after 2 days in
brain heart infusion broth, were stained with Gram and modified Kinyoun stains.
Biochemical identification tests.
Mycobacterial
identification tests and tests for hydrolysis of xanthine,
hypoxanthine, and tyrosine were performed by standard procedures
(3, 18). The results of tests with xanthine and hypoxanthine were read weekly for 3 weeks, and the results of tests
with tyrosine were read weekly for 4 weeks. Testing with the API Coryne
system (version 2.0), the API 20C AUX system, the API 50 CH system, and
the APIZYM system (bio Mérieux Vitek, Hazelwood, Mo.) and the
RapID CB Plus system (Remel) was done according to the manufacturers'
instructions. Reactions with the API Coryne system were read after
incubation for 24 h for enzymes and for 2, 4, and 7 days for sugars.
The API 20C AUX strips were read at 2 and 6 days, and the results were
reported at 6 days. The APIZYM and RapID CB Plus systems were incubated
for 4 h. For the API 50 CH strips, inocula were suspended in API
50 CHB broth (bioMérieux) and tests were read daily, with the
final reading taken at 5 days. Incubation beyond 5 days gave weak
reactions in many wells that were interpreted as nonspecific. Testing
with commercial strips was done twice, and the results were read by two
observers to evaluate reproducibility. Only assimilation results were
considered for the API 50 CH system because oxidation and fermentation
reactions were weak, difficult to interpret, and nonreproducible on
repeated testing. Sugar assimilations in the API 20C AUX and API 50 CH systems were read as positive when heavy growth in the cupules obscured
the underlying stripes.
Susceptibility testing.
E-tests (AB BIODISK, Solna, Sweden)
were done according to the manufacturer's instructions. Inocula were
prepared by touching five colonies with an applicator stick and
suspending the cells in 3 ml of Mueller-Hinton broth supplemented with
Tween 80 to a final concentration of 0.7%. Cell suspensions were
vortexed, and large clumps were allowed to settle before dilution to
match a 0.5 McFarland turbidity standard. Six E-test strips were
applied to each inoculated 150-mm plate of Mueller-Hinton agar. The
plates were incubated in an aerobic atmosphere at 35°C, and the
E-test MICs were read daily for 3 days.
GLC.
Whole-cell short-chain fatty acid analyses were
performed by GLC with the MIS essentially as described by Leonard et
al. (16). The manufacturer's protocol was followed for
cell growth, harvesting, saponification, methylation, extraction, and
chromatography with a Hewlett-Packard 5890 Series II gas chromatograph
with an electronic pulse control and sample controller. Data were
integrated and analyzed with a Hewlett-Packard Vectra computer with
MIDI Sherlock Library Generation Software (version 1.06) to compare the
experimental chromatographic profiles with both the Clinical library
(version 4.0) and the Mycobacterial library (version 3.8) of MIDI.
HPLC.
The whole-cell mycolic acid extraction procedure and
the internal standards were as described by Springer et al.
(25). The Beckman HPLC system consisted of a 507 autosampler, a 126 pump, a detector set at 260 nm, and a
cartridge-style ultrasphere column (4.5 mm by 7.5 cm with 3-µm
particles) with a guard column and a Dell Dimension (XPS P100 C)
computer system loaded with Beckman System Gold Nouveau software.
Samples were analyzed at 35°C by the standard method recommended by
the HPLC User's Group. Relative retention times were calculated by
assigning "0" to the injection time and "1" to the peak of the
high-molecular-weight internal standard. These standards were used to
convert the absolute retention times of peaks to relative retention
times. To evaluate pattern reproducibility within species, HPLC
analyses were performed at least twice for all isolates.
DNA-DNA hybridizations.
DNA-DNA hybridizations were
performed by dot blot analysis. Chromosomal DNA was prepared from cells
that were incubated with shaking at 37°C for 48 h in 200 ml of brain
heart infusion broth (Difco Laboratories, Detroit, Mich). DNA
extraction was done by the protocol described by Thierry et al.
(28). Chemiluminescent probe labeling, hybridization, and
signal detection with the NE Blot Phototope kit (New England Biolabs,
Inc., Beverly, Mass.) and the PolarPlex Chemiluminescent Blotting kit
(New England Biolabs, Inc.) were performed as recommended by the
manufacturer, with hybridization and washing temperatures set at
68°C. The hybridization signal intensity was evaluated visually and
graded semiquantitatively on a scale of 0 to 4, with 0 indicating no
signal detected and 4 indicating a strong signal from homologous
DNA-DNA hybridization derived from a single isolate.
16S rRNA gene sequencing.
The 16S rRNA genes of T. paurometabola type strain ATCC 8368, T. paurometabola
ATCC 25938, T. inchonensis type strain ATCC 700082, and
T. strandjordae were sequenced in their entirety. The 16S
rRNA gene PCR amplification was performed with primers 8FPL and DG74
(positions 8 to 27 and 1522 to 1540 [Escherichia coli
numbering], respectively) (12, 22) on a thermocycler (model 9700, Perkin-Elmer Applied Biosystems, Foster City, Calif.) as
described previously (14). After column purification of
the PCR products (Microcon 100; Amicon, Beverly, Mass.), primers 8FPL, 516F, 516R, 806F, 806R, 1175F, 1175R (8, 22), and DG74
were used for cycle sequencing with the Reaction Ready Big Dye
terminator kit (Perkin-Elmer Applied Biosystems) on a Perkin-Elmer
Applied Biosystems model 9700 thermocycler. Sequencing products were
column purified (CentriSep, Adelphia, N.J.) and analyzed on an API
PRISM 377 (Perkin-Elmer Applied Biosystems). For all other strains, after full gene amplification, we performed partial sequencing of the
first 500 bp with primers 8FPL and 516R. Sequences were assembled and
edited by using Sequencher software (version 3.1; Gene Codes Corp., Ann
Arbor, Mich.).
Phylogenetic analysis.
The 16S rRNA gene sequence of
T. strandjordae and partial sequences of clinical isolates
were searched against the GenBank database by using the gapped BLAST
program (1). The first 15 matches of GenBank sequences to
the T. strandjordae sequence all corresponded to
Tsukamurella species entries. Among these, the following
type and reference strain sequences were retrieved from GenBank:
T. paurometabola type strain ATCC 8368 (accession nos. X80628 and Z46751), T. paurometabola ATCC 25938 (accession no. Z36933), T. paurometabola strain M334 (accession no.
Z37151), T. inchonensis type strain ATCC 700082 (accession
no. X85955), T. pulmonis type strain ATCC 700081 (accession
no. X92981), T. pulmonis strain KUL50 (accession no.
AF001011), T. tyrosinosolvens type strain DSMZ 44234 (accession no. Y12246), T. tyrosinosolvens strains D-1411,
D-1437 and D-1498 (accession nos. Y12248, Y12247, and Y12245,
respectively), T. wratislaviensis (accession no. Z37138),
and Tsukamurella spumae (accession no. Z37150, an invalidly
named species). Sequences were also retrieved from GenBank for
representative reference strains of closely related mycolic
acid-containing genera including Rhodococcus equi (accession no. X80614), Rhodococcus rhodocrous (accession no. X79288), Nocardia asteroides (accession no. X84850), Nocardia
otitidis-N. caviarum (accession no. X80611), Mycobacterium
chelonae (accession no. M29559), Dietzia maris
(accession no. X81920), Gordonia terrae (accession no.
AF154833), Skermania piniformis (accession no. Z35435),
Williamsia murale (accession no. Y17384), and Corynebacterium diphtheriae (accession no. X82059). These
sequences, along with the complete sequences generated in the present
study for T. strandjordae, T. paurometabola type strain ATCC
8368, T. paurometabola ATCC 25938, and T. inchonensis type strain ATCC 700082, were aligned by using the
CLUSTAL_X program (29). The multiple-sequence-alignment
output was trimmed and manually edited with the JalView program (M. Clamp, European Bioinformatics Institute [http://circinus.ebi.ac.uk:6543/jalview/]) and Microsoft Word (Microsoft, Redmond, Wash.). Phylogenetic analyses were performed with the PHYLIP program (J. Felsenstein, Department of Genetics, University of Washington
[http://evolution.genetics.washington.edu/phylip.html]) with
the neighbor-joining, maximum-likelihood and maximum-parsimony algorithms by using the default parameters with the NEIGHBOR, DNAML,
and DNAPARS, programs, respectively. Bootstrap analysis (7) with 1,000 replications for each algorithm was
performed with the SEQBOOT program in the PHYLIP software
package. Alignment of the Tsukamurella 16S rRNA gene
sequences derived from reference strains and submitted by different
investigators with those of related members of the order
Actinomycetales allowed us to discern species-specific
signature sequences, even though infrageneric sequence similarities
among Tsukamurella species, with the exception of T. wratislaviensis, exceeded 99% (data not shown). These signature sequences were used for species-level identification of the clinical isolates.
Nucleotide sequence accession numbers.
The complete 16S rRNA
gene sequences of T. strandjordae, T. paurometabola ATCC
8368, T. paurometabola ATCC 25938, and T. inchonensis ATCC 700082 have been deposited in GenBank under the
following accession nos.: AF283283, AF283280, AF283282, and AF283281 respectively.
 |
RESULTS |
Microscopic and colonial morphologies.
With the exception of
T. paurometabola and T. wratislaviensis, colonies
of Tsukamurella species shared common features. Colonies of
T. strandjordae, T. inchonensis, T. pulmonis, and T. tyrosinosolvens, visible after 48 h of incubation on Middlebrook
7H11 agar or TSA, were up to 5 mm in diameter, dry, rough, velvety, and
flat and slightly raised in the central one-third to one-half of the
colony with fringed edges. Colonies of T. pulmonis and
T. tyrosinosolvens were nonpigmented gray-tan and dark tan
or buff, respectively. In contrast, colonies of T. strandjordae and T. inchonensis including T. paurometabola ATCC 25938 (identified as T. inchonensis
[see below]) were indistinguishable and were pigmented yellow to
orange. Colonies of the T. paurometabola type strain had a
distinctive fried-egg appearance. These colonies were 2 to 5 mm in
diameter, smooth creamy with entire edges, gray, and flat with a tan
raised center. Colonies of T. wratislaviensis were up to 3 mm in diameter, gray, rough, and uniformly raised. The colonial
morphology on tap water agar visualized under ×20 magnification for
T. strandjordae, T. inchonensis, T. pulmonis, and T. tyrosinosolvens showed a biphasic pattern: complex branching forms
with a frost-like appearance of substrate hyphae resembling rapidly
growing mycobacteria and coccobacillary forms arranged in a classic
diphtheroid fashion without production of aerial hyphae. In contrast,
T. paurometabola and T. wratislaviensis grew only
at the surface of the agar as coccobacilli in diphtheroid arrangements.
The Gram staining morphologies for T. strandjordae, T. inchonensis, T. pulmonis, and T. tyrosinosolvens were
identical. Cells consisted of long, rod-shaped forms resembling nontuberculous mycobacteria that were gram positive, and by staining with the modified Kinyoun stain, the cells were irregularly positive throughout the smear. Gram staining was generally nonhomogeneous and
sometimes beaded. Cells of T. paurometabola type strain ATCC 8368 were diphtheroid, Gram stain variable, and modified Kinyoun stain
positive. Cells of T. wratislaviensis were gram-positive coccobacilli and were occasionally positive by staining with the modified Kinyoun stain.
Physiological and biochemical tests.
Standard biochemical
tests for acid-fast bacilli showed that all isolates except T. wratislaviensis were resistant to lysozyme, positive for
semiquantitative catalase and 68°C heat-stable catalase, Tween 80 hydrolysis at 5 days, urease, pyrazinamidase, Fe uptake, and tolerance
to 5% NaCl at 1 week and negative for nitrate reduction after 2 weeks
and arylsulfatase after 3 and 14 days. All except T. wratislaviensis and two isolates of T. tyrosinosolvens
grew on MacConkey agar without crystal violet after 11 days, but growth after 5 days was inconsistent among all species. None of the isolates grew anaerobically. The results obtained with the API Coryne (version 2.0), RapID CB Plus, and API 20C AUX systems are summarized in Table
1. The profile numbers obtained at 2 days
with the API Coryne system corresponded either to Corynebacterium
aquaticum (profile no. 2550004) or R. equi (profile no.
2150004) or gave no identification (profile no. 2551004). In the RapID
CB Plus system, except for profile no. 0623531, which had no match in the database, all other profiles corresponded to R. equi. T. wratislaviensis gave profile no. 0207531, which also corresponds
to R. equi. T. strandjordae displayed a unique profile in
the API 20C AUX system and the API Coryne system after 4 days of
incubation (Table 1).
The sugar assimilation results obtained with the API 20C AUX and API 50 CH systems were reproducible on repeated testing and when the tests
were evaluated by two observers. Among the commercial systems, the API
50 CH system was the most helpful in distinguishing T. paurometabola and T. pulmonis from the other
Tsukamurella species. Testing with the API 50 CH system in
combination with standard biochemicals for mycobacteria, temperature
responses, and degradation agars allowed us to identify all
tsukamurellae to the species level. All sugars included in the API 20C
AUX system are part of the API 50 CH system, which contains 30 additional tests. However, both systems were used because the sugar
utilization results obtained with both the API Coryne and the RapID CB
Plus systems were uniformly negative. Some discrepancies were observed
between the API 20C AUX and the API 50 CH systems (Table
2). However, within each system, sugar
assimilation results were generally reproducible on repeated testing.
All 14 tested isolates utilized glucose, galactose, saccharose,
trehalose, D-fructose, D-turanose, gluconate, and N-acetyl-D-glucosamine as a sole carbon
source; and all failed to utilize L-arabinose,
D-xylose, adonitol, cellobiose, lactose, raffinose,
erythritol, L-xylose, D-fucose,
L-sorbose, rhamnose, dulcitol, melibiose, starch, glycogen,
-gentiobiose, D-lyxose, D-tagatose,
L-arabitol, amygdaline, 5-ketogluconate,
-methylxyloside, and
-methyl-D-mannoside as a sole
carbon source. Differential results for Tsukamurella species
with the API 20C AUX and the API 50CH systems and degradation agars and
their temperature responses are presented in Table 2. All strains
uniformly hydrolyzed esculin in the API Coryne, RapID CB Plus, and API
50 CH systems. The leucine-
-naphthylamide test was positive in both
the RapID CB Plus system and the API ZYM system for all tsukamurellae
including T. wratislaviensis. It is noteworthy that the
urease test with the urea disk was positive for all isolates, although
it was negative in the API Coryne and RapID CB Plus systems. The
reactions in the API ZYM system were identical for all
Tsukamurella strains except T. wratislaviensis. As recommended by the manufacturer, reactions were graded on a scale of
0 to 5, with reactions graded 0 to 2 considered negative. They were
positive for 2-naphthylphosphate, 2-naphthylcaprylate, L-leucyl-2-naphthylamide, naphthol-AS-BI-phosphate,
2-naphthyl-
-D-glucopyranoside, and
bromo-2-naphthyl-
-D-glucopyranoside. T. wratislaviensis could be distinguished from other
Tsukamurella species by being negative for
2-naphthylphosphate, 2-naphthylcaprylate, and
bromo-2-naphthyl-
-D-glucopyranoside and positive for
L-valyl-2-naphthylamide and
L-cystyl-2-naphthylamide.
Lipid analyses.
The results of short-chain fatty acid methyl
ester (FAME) analyses by GLC chromatography are shown in Table
3. T. paurometabola and
T. wratislaviensis are the only Tsukamurella
species included in the current Clinical (version 4.0) and
Environmental (Trypticase soy broth agar; version 4.0) libraries of the
MIDI database, and analyses of FAMEs with chain lengths of 20 carbons
or less have not previously been reported for other
Tsukamurella species. Similar to other aerobic
actinomycetes, the FAME contents of all tsukamurellae consist of a
combination of straight-chain saturated and monounsaturated fatty acids
and, with the exception of a single clinical isolate of T. pulmonis, tuberculostearic acid (C18:0 10 methyl). The
proportions of some FAMEs exhibited wide variation within species and
variations for a single isolate between the clinical and
mycobacteriological methods. In addition, the fatty acid profiles
overlapped among various Tsukamurella species and with those
of other aerobic actinomycetes and mycobacteria in the MIDI Clinical
and Mycobacterial libraries, respectively. However, by the clinical
method, T. pulmonis could be distinguished from other
tsukamurellae by a higher proportion of 20:1
9C fatty acids
(>4.5%), whereas all other species contained <2% 20:1
9C fatty
acids. Interestingly, even though T. wratislaviensis is
included in the Clinical library of the MIDI database, it was misidentified as Nocardia brasiliensis by the MIS with a
high degree of probability (similarity index, 0.664).
HPLC analysis of mycolic acids yielded similar chromatographic profiles
for all Tsukamurella species with the exception of T. wratislaviensis. These profiles consisted of a characteristic single cluster of poorly resolved peaks that were not sufficiently distinctive for species identification. The overall relative retention times of these peaks ranged from 6.25 to 7.50 min, but the last peak to
emerge was often hard to define. The chromatographic profile of
T. wratislaviensis was unique compared to those for the
other tsukamurellae and exhibited two clusters of peaks that eluted much earlier: the early peaks were obscured by the solvent front and
the last peak emerged at 5 min. These data suggest that T. wratislaviensis possesses shorter-chain mycolic acids than other Tsukamurella species.
Antimicrobial susceptibility.
By using the National Committee
for Clinical Laboratory Standards (NCCLS) interpretive guidelines for
the family Enterobacteriaceae and Staphylococcus
species, T. paurometabola could be distinguished by its high
level of resistance to imipenem (MIC, >32 µg/ml), whereas all other
isolates were susceptible to imipenem (MICs, <1 µg/ml for all except
one clinical isolate of T. inchonensis, for which the
imipenem MIC was 4 µg/ml). T. wratislaviensis was susceptible to cefoxitin (MIC, 8 µg/ml), whereas the other isolates were highly resistant to cefoxitin-(MICs, >256 µg/ml). T. strandjordae and two clinical isolates of T. pulmonis
were intermediately susceptible to gentamicin, but all other strains
were fully susceptible to gentamicin. The susceptibility profile of
T. strandjordae with the other antimicrobials tested
otherwise resembled those of strains of T. pulmonis, T. inchonensis, and T. tyrosinosolvens (see description of
new taxon below). A more detailed description of the antimicrobial susceptibility of the Tsukamurellae will be reported elsewhere (M. A. Schwartz et al., submitted for publication).
DNA-DNA hybridizations, 16S rRNA gene sequencing, and phylogenetic
analyses.
DNA-DNA hybridizations and 16S rRNA gene sequencing
confirmed that T. strandjordae is a novel bacterium and
allowed us to assign all clinical isolates to their respective species.
Hybridization experiments, performed twice with T. strandjordae, showed strong hybridization signals (4+) with
homologous DNA, weak signals (1+ or 2+) with DNAs from isolates of
T. inchonensis, T. paurometabola, T. pulmonis, and T. tyrosinosolvens, and no signal with DNA from T. wratislaviensis (data not shown). T. paurometabola ATCC
25938 displayed a strong hybridization signal (4+) with DNA from
T. inchonensis type strain ATCC 70082 and homologous DNA,
weak hybridization signals (1+ or 2+) with DNAs from T. strandjordae, T. pulmonis, and T. tyrosinosolvens, and
no signal with DNAs from T. wratislaviensis and the type
strain T. paurometabola ATCC 8368. Except for homologous DNA, T. wratislaviensis exhibited no hybridization with the
DNA of any other isolate. Similarly, isolates of T. pulmonis, T. inchonensis, and T. tyrosinosolvens displayed signals
of 3+ or 4+ within species and with homologous DNA and signals of 0, 1+, or, less commonly, 2+ with DNAs from isolates of other species.
Our hybridization results were supported by 16S rRNA gene sequencing.
Strain pairs that displayed strong DNA-DNA hybridization signals (3+ or
4+) had identical 16S rRNA gene signature sequences in pairwise
sequence comparisons. Likewise, the 16S rRNA gene sequence of T. wratislaviensis differed by more than 4% from the rRNA gene
sequences of all other Tsukamurella species tested, as
predicted from DNA-DNA hybridization data. Except at a single position,
the sequence of T. strandjordae was identical to that found
in GenBank for a strain designated T. paurometabola M334; however, its sequence differed from that of T. paurometabola
ATCC 8368 at 9 positions, including 2 insertions or deletions, and from
that of T. paurometabola ATCC 25938 at 10 positions.
Phylogenetic analyses with three treeing algorithms showed that
T. strandjordae and T. paurometabola strain M334
formed a distinct branch within the Tsukamurella clade with
strong bootstrap support (Fig. 1) and
thus merit assignment to a novel species. Pairwise sequence comparisons
with other Tsukamurella species showed that T. strandjordae differed from T. inchonensis type strain
ATCC 700082 at 10 positions, from T. pulmonis type strain
ATCC 700081 at 6 positions, from T. tyrosinosolvens type
strain DSMz 44234 at 4 positions, from T. spumae at 8 positions including 2 insertions or deletions, and from T. wratislaviensis at 61 positions. We also found that the complete
16S rRNA gene sequence of T. paurometabola ATCC 25938 is
100% identical to that of T. inchonensis type strain ATCC
700082. These data, together with DNA-DNA hybridization and phenotypic data, provide strong evidence that T. paurometabola ATCC
25938 is a misnamed T. inchonensis strain.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
Neighbor-joining dendrogram based on 1,311 consecutive
positions of the 16S rRNA gene with 1,000 bootstrap replications
showing the phylogenetic relationships of T. strandjordae
and T. paurometabola (T. inchonensis) ATCC 25938 with other tsukamurellae and select related corynebacterineae of the
order Actinomycetales. C. diphtheriae was chosen as the
outgroup. Numbers at each node correspond to the bootstrap values.
GenBank nucleotide sequence accession numbers are also included for the
tsukamurellae. The sequences in GenBank for T. paurometabola
ATCC 8368 (accession no. Z46751 and X80628), T. paurometabola ATCC 25938 (accession no. Z36933), and T. inchonensis ATCC 70082 (accession no. X85955) were identical to
those generated in this study and were therefore not included in the
dendrogram.
|
|
 |
DISCUSSION |
The taxonomic history of the genus Tsukamurella has
been reviewed extensively by Yassin et al. (34). The type
species T. paurometabola, isolated from the ovaries of bed
bugs, was initially described by Steinhaus as Corynebacterium
paurometabolum. In a comprehensive numerical phenetic study by
Jones (13), the type strain of C. paurometabolum ATCC 8368 was found to be quite distinct from
Corynebacterium species. The first human isolate of
Tsukamurella, named Gordona aurantiaca, was
identified in the sputum of a patient with tuberculosis, but its causal
role in disease was questioned (33). In 1985, G. aurantiaca was renamed Rhodococcus aurantiacus by
Tsukamura and assigned a new type strain, ATCC 25938 (31). Chemical and numerical taxonomic studies of C. paurometabolum and G. aurantiaca (5, 9)
revealed that they had similar cellular compositions. Thus, in 1988, on
the basis of these data, the >99% similarity of the 16S rRNA gene
sequences, and the phylogenetic positions of strain ATCC 8368 and
strain 25938 among other members of the order
Actinomycetales, Collins and colleagues (6)
concluded that they be assigned to a new genus,
Tsukamurella, and that they belong to a single species,
Tsukamurella paurometabolum. They designated ATCC 8368 as
the type strain. Yassin later correctly renamed T. paurometabolum T. paurometabola (34).
Since the proposal of the genus in 1988, clinical infections associated
with tsukamurellae were mostly attributed to T. paurometabola; however, the published descriptions of these
clinical isolates do not resemble the description of T. paurometabola type strain ATCC 8368. Auerbach et al.
(2) first noted heterogeneity within the genus
Tsukamurella in 1992. They reported a common-source outbreak
of pseudoinfection in 10 patients caused by T. paurometabola
resulting from laboratory contamination. Similar to our observations,
they found that the new type strain, ATCC 8368, differed from the
outbreak isolates and from the original type strain, ATCC 25938, in
terms of colonial morphology, biochemistry, antimicrobial
susceptibility, and ribotyping. McNabb et al. (17) also
found that strains ATCC 8368 and ATCC 25938 differed in their cellular
fatty acid contents, suggesting the possibility of separate species.
From 1995 to 1997, Yassin et al. (34-36) proposed three
additional species, T. pulmonis, T. inchonensis and T. tyrosinosolvens, all of which were isolated from human samples.
By comparing type and reference strains of Tsukamurella to
clinical isolates, we were able to identify another
Tsukamurella species closely related to but distinct from
T. pulmonis, T. inchonensis, T. paurometabola, and T. tyrosinosolvens. Our patient's isolate, T. strandjordae, was the sole bacterium grown repeatedly from cultures of blood from a 5-year-old girl with acute myelogenous leukemia and thus adds to the growing list of aerobic actinomycetes causing opportunistic infections. This organism is characterized by a
unique 16S rRNA gene sequence and does not hybridize strongly with any
other Tsukamurella species. The 16S rRNA sequence of our
unique isolate, T. strandjordae, differs at only one
position from that listed in GenBank for another strain, M334,
identified as T. paurometabola. Therefore, we believe that
strain M334 most likely belongs to our newly proposed species, T. strandjordae. We could not obtain strain M334 to compare it with
our isolate. However, strain M334 was included in a polyphasic
taxonomic study of Gordonia and Tsukamurella
(10), in which it exhibited low-level DNA-DNA
hybridization (<45%) with other Tsukamurella strains
including strain N663, synonymous with T. paurometabola ATCC
25938. However, the current type strain, T. paurometabola
ATCC 8368, was not included in that study. Considering a DNA homology
threshold of 70% for species definition (26), these data
suggest that strain M334 is closely related to other
Tsukamurella strains tested in that study but is a separate
species. Our study also showed that T. paurometabola strain
ATCC 25938, formerly G. aurantiaca, belongs to T. inchonensis on the basis of the 100% identity of its 16S rRNA
gene sequence to the 16S rRNA gene sequence of T. inchonensis type strain ATCC 70082, the high level of DNA-DNA
hybridization between the two strains, and the concordant phenotypic
data for the two strains.
The pathogenic role of tsukamurellae has been debated. Since the
initial report by Tsukamura and Kawakami (32) of a lung infection that mimicked tuberculosis caused by G. aurantiaca
in 1982, several cases of human infection have been described primarily in immunocompromised patients or patients with predisposing conditions but occasionally in immunocompetent hosts as well (11, 15, 19-21, 23, 24, 30; R. F. Haft, C. L. Shapiro, N. M. Gantz, J. C. Christenson, and R. J. Wallace, Jr., Letter, Clin.
Infect. Dis. 15:883, 1992; R. S. Jones, T. Fekete,
A. L. Truant, and V. Satishchandran, Letter, Clin. Infect. Dis.
18:830-832, 1994; K. K. Lai, Letter, Clin. Infect.
Dis. 17:285-287, 1993; D. Rey, D. De Briel, R. Heller, P. Fraisse, M. Partisani, M. Leiva-Mena, and J. M. Lang, Letter, AIDS
9:1379, 1995). Some reports indicate that these organisms
were isolated concomitantly with other bacteria and that they were
considered environmental contaminants. However, cases of
catheter-related infection, peritonitis, fatal meningitis, and bone
infection in which tsukamurellae were the sole isolates suggest that
these organisms are potential opportunistic pathogens. In some of
these patients, Tsukamurella species were repeatedly
isolated over a several-month period and could not be eradicated,
despite polyantimicrobial therapy (30, 32).
On the basis of its sugar utilization profile and short-chain fatty
acid content, T. strandjordae could be easily distinguished from T. paurometabola and T. pulmonis, but
distinction from T. inchonensis and T. tyrosinosolvens was based on a few tests, namely, temperature
responses and hydrolysis of hypoxanthine and tyrosine. With few
discrepancies, our study of 15 strains of Tsukamurella generally showed good agreement between our phenotypic data and those
reported by Yassin et al. for T. paurometabola, T. inchonensis, T. pulmonis, and T. tyrosinosolvens
(34-36). Testing for sugar utilization with the API 50 CH
system showed excellent correlation with published data based on tests
with conventional biochemicals. However, with degradation agars, we
found inconsistencies among different studies and with our results
(2, 24, 34-36). Moreover, in our study we found
discrepancies between different commercial systems. For example, it is
noteworthy that sugar utilization tests and the urease tests were
negative throughout or occasionally weakly positive in the API Coryne
and RapID CB Plus systems. The test for
-galactosidase reportedly
one of the distinguishing features between Tsukamurella and
Rhodococcus species (32), in the API Coryne
system was negative for >50% of the strains tested. Tsukamurella
strains which lack
-galactosidase activity have been reported by
others (21, 30). The discrepancies that were encountered
could be attributed to the lack of metabolic substrates in basal media
that would favor expression of certain characteristics in some
organisms, phenotypic variability within species, or variation in
experimental conditions.
Analysis of short-chain fatty acids was helpful only for the separation
of T. pulmonis and T. wratislavensis from
other Tsukamurella species, but distinction from
other aerobic actinomycetes and Mycobacterium species was
inconsistent. We did not expect our fatty acid profiles to be
comparable to those of McNabb et al. (17) since we used
different media (TSA and Middlebrook 7H11 agar versus Trypticase soy
agar), different culture incubation periods (48 versus 96 h), and
a different temperature (28 versus 35°C), as recommended by the
manufacturer. These parameters are well recognized to have a critical
impact when these profiles are used for bacterial
identification. Mycolic acid analyses by HPLC are useful in
distinguishing clinical isolates of tsukamurellae from related
mycolic acid-containing bacteria but do not distinguish the different species.
Another interesting observation in our study was that
T. wratislaviensis is distant from other
Tsukamurella species both in phenotype and by its 16S rRNA
sequence. T. wratislaviensis was originally found in soil
and to our knowledge has never been isolated from a human source. We
found that T. wratislaviensis contains mycolic acids of a
shorter chain length compared to those for other
Tsukamurella species. Our phylogenetic data revealed that T. wratislaviensis forms a phyletic line distinct from the
Tsukamurella clade (100% boostrap support) and clusters
with Rhodococcus and Nocardia species. A BLAST
search of the sequences in GenBank showed that T. wratislaviensis is most closely related to Rhodococcus opacus with 99.7% 16S rRNA gene sequence (GenBank accession no. X80631) similarity, strongly suggesting that T. wratislaviensis belongs to the genus Rhodococcus
(36).
Description of Tsukamurella strandjordae sp. nov.
Tsukamurella strandjordae sp. nov. (strandjordae,
in honor of Paul Strandjord, founder and chair of the Department of
Laboratory Medicine, University of Washington, from 1969 to 1994).
Cells are strictly aerobic, long, gram-positive rods and are slightly
acid-fast with the modified Kinyoun stain. Abundant growth is observed
after 48 h on Trypticase soy agar, Middlebrook 7H11 agar, nutrient
agar, and MacConkey agar without crystal violet. Colonies are rough and
pigmented tan to yellow, and range in size from 2 to 5 mm in diameter.
The organism grows at 28 and 35°C but not at 42°C. On tap water
agar it produces short, branching substrate hyphae and diphtheroid
forms but no aerial hyphae. It does not hydrolyze xanthine,
hypoxanthine, or tyrosine. It is positive for semi quantitative
catalase and 68°C heat-stable catalase, Tween 80 hydrolysis at 5 days, urease, pyrazinamidase, 5% NaCl tolerance, and iron uptake. It
does not hydrolyze nitrate at 2 weeks and is negative for arylsulfatase
at 3 and 14 days. The numerical profile with the API Coryne system
after 2 days is 2550004, that with the RapID CB Plus system after
4 h is 0627511, and that with the API 20C AUX system after 6 days is 6063160. In the API 50 CH system it can utilize galactose,
D-glucose, D-fructose, D-mannose,
maltose, saccharose, trehalose, melezitose, D-turanose, L-fucose, gluconate, inositol, mannitol, sorbitol,
D-arabitol, L-arabitol,
-methyl-D-glucoside, N-acetylglucosamine,
arbutine, salicine, and 2-ketogluconate as a sole carbon source and
hydrolyzed esculin. It does not utilize erythritol,
D-arabinose, L-arabinose, ribose,
D-xylose, L-xylose, adonitol,
-methylxyloside, L-sorbose, rhamnose, dulcitol,
-methyl-D-mannoside, amygdaline, cellobiose, lactose,
melibiose, inuline, D-raffinose, starch, glycogen, xylitol,
-gentiobiose, D-lyxose, D-fucose,
L-fucose, gluconate, or 5-ketogluconate as a sole
carbon source. In the API ZYM system it is positive only for
2-naphthylphosphate, 2-naphthylcaprylate,
L-leucyl-2-naphthylamide, 2-naphthyl-
-D-glucopyranoside, and
bromo-2-naphthyl-
-D-glucopyranoside. It contains
short, straight-chain saturated and monounsaturated fatty acids and
tuberculostearic acid and long-chain mycolic acids, forming a single
cluster of peaks on HPLC. It can be distinguished from T. paurometabola and T. pulmonis by assimilation of
inositol, D-mannose, arbutine, salicin, and inulin and can
be distinguished from T. inchonensis and T. tyrosinosolvens by the absence of growth at 42°C and a lack of
assimilation of hypoxanthine and tyrosine. By the E-test it is
susceptible to imipenem, amikacin, clarithromycin, ciprofloxacin, and
trimethoprim-sulfamethoxazole. It has intermediate susceptibility to
gentamicin and is resistant to cefoxitin, cefotaxime, tobramycin,
erythromycin, and azithromycin (Schwartz et al., submitted). It is
characterized by a unique 16S rRNA gene sequence (GenBank accession no.
AF283283). The type strain has been deposited at the ATCC as strain
ATCC BAA-173.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Laboratory Medicine, Harborview Medical Center, Box 359743, 325 Ninth Ave., Seattle, WA 98104. Phone: (206) 731-3311. Fax: (206) 731-3930. E-mail: mbcoyle{at}u.washington.edu.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Auerbach, S. B.,
M. M. McNeil,
J. M. Brown,
B. A. Lasker, and W. R. Jarvis.
1992.
Outbreak of pseudoinfection with Tsukamurella paurometabolum traced to laboratory contamination: efficacy of joint epidemiological and laboratory investigation.
Clin. Infect. Dis.
14:1015-1022[Medline].
|
| 3.
|
Brown, J. M.,
M. M. McNeil, and E. P. Desmond.
1999.
Nocardia, Rhodococcus, Gordona, Actinomadura, Streptomyces, and other actinomycetes of medical importance, p. 370-398.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
|
| 4.
|
Clausen, C., and C. K. Wallis.
1994.
Bacteremia caused by Tsukamurella species.
Clin. Microbiol. Newsl.
16:6-8.
|
| 5.
|
Collins, M. D., and D. Jones.
1982.
Lipid composition of Corynebacterium paurometabolum.
FEMS Microbiol. Lett.
13:13-16.
|
| 6.
|
Collins, M. D.,
J. Smida,
M. Dorsch, and E. Stackebrandt.
1988.
Tsukamurella gen. nov. harboring Corynebacterium paurometabolum and Rhodococcus aurantiacus.
Int. J. Syst. Bacteriol.
38:385-391.
|
| 7.
|
Felsenstein, J.
1985.
Confidence limits on phylogenies: an approach using the bootstrap.
Evolution
39:783-791[CrossRef].
|
| 8.
|
Fredricks, D. N., and D. A. Relman.
1998.
Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetholesulfonate.
J. Clin. Microbiol.
36:2810-2816[Abstract/Free Full Text].
|
| 9.
|
Goodfellow, M.,
P. A. B. Orlean,
M. D. Collins,
L. Alshamaony, and D. E. Minnikin.
1978.
Chemical and numerical taxonomy of strains received as Gordona aurantiaca.
J. Gen. Microbiol.
109:57-68.
|
| 10.
|
Goodfellow, M.,
J. Zakrzewska-Czerwinska,
E. G. Thomas,
M. Mordarski,
A. C. Ward, and A. L. James.
1991.
Polyphasic taxonomic study of the genera Gordona and Tsukamurella including the description of Tsukamurella wratislaviensis sp. nov.
Zentbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig.
275:162-178.
|
| 11.
|
Granel, F.,
A. Lozniewski,
A. Barbaud,
C. Lion,
M. Dailloux,
M. Weber, and J. L. Schmutz.
1996.
Cutaneous infection caused by Tsukamurella paurometabolum.
Clin. Infect. Dis.
23:839-840[Medline].
|
| 12.
|
Greisen, K.,
M. Loeffelholz,
A. Purohit, and D. Leong.
1994.
PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.
J. Clin. Microbiol.
32:335-351[Abstract/Free Full Text].
|
| 13.
|
Jones, D.
1975.
Numerical taxonomy of coryneform and related bacteria.
J. Gen. Microbiol.
87:52-96[Medline].
|
| 14.
|
Kattar, M. M.,
J. F. Chavez,
A. P. Limaye,
S. L. Rassoulian-Barrett,
S. L. Yarfitz,
L. C. Carlson,
Y. Houze,
S. Swanzy,
B. L. Wood, and B. T. Cookson.
2000.
Application of 16S rRNA gene sequencing to identify Bordetella hinzii as the causative agent of fatal septicemia.
J. Clin. Microbiol.
38:789-794[Abstract/Free Full Text].
|
| 15.
|
Larkin, J. A.,
L. Lit,
J. Sinnott,
T. Wills, and A. Szentivanyi.
1999.
Infection of a knee prosthesis with Tsukamurella species.
South. Med. J.
92:831-832[Medline].
|
| 16.
|
Leonard, R. B.,
D. J. Nowowiejski,
J. J. Warren,
D. J. Finn, and M. B. Coyle.
1994.
Molecular evidence of person-to-person transmission of a pigmented strain of Corynebacterium striatum in intensive care units.
J. Clin. Microbiol.
32:164-169[Abstract/Free Full Text].
|
| 17.
|
McNabb, A.,
R. Shuttleworth,
R. Behme, and W. D. Colby.
1997.
Fatty acid characterization of rapidly growing pathogenic aerobic actinomycetes as a means of identification.
J. Clin. Microbiol.
35:1361-1368[Abstract].
|
| 18.
|
Metchock, B. G.,
F. S. Nolte, and R. J. Wallace, Jr.
1999.
Mycobacterium, p. 399-437.
In
P. R. Murray, E. J. Barron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
|
| 19.
|
Min, Y.,
M. Asano,
M. Kohanawa, and T. Minagawa.
1999.
Movement disorders in encephalitis induced by Rhodococcus aurantiacus infection relieved by the administration of L-dopa and anti-T-cell antibodies.
Immunology
96:10-15[CrossRef][Medline].
|
| 20.
|
Osoagbaka, O. U.
1989.
Evidence for the pathogenic role of Rhodococcus species in pulmonary diseases.
J. Appl. Bacteriol.
66:497-506[Medline].
|
| 21.
|
Prinz, G.,
E. Ban,
S. Fekete, and Z. Szabo.
1985.
Meningitis caused by Gordona aurantiaca (Rhodococcus aurantiacus).
J. Clin. Microbiol.
22:472-474[Abstract/Free Full Text].
|
| 22.
|
Relman, D. A.
1993.
Universal bacterial 16S rRNA amplification and sequencing, p. 489-495.
In
D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
|
| 23.
|
Rey, D.,
P. Fraisse,
P. Riegel,
Y. Piemont, and J. M. Lang.
1997.
Tsukamurella infections. Review of the literature apropos of a case.
Pathol. Biol. (Paris)
45:60-65[Medline]. (In French.)
|
| 24.
|
Shapiro, C. L.,
R. F. Haft,
N. M. Gantz,
G. V. Doern,
J. C. Christenson,
R. O'Brien,
J. C. Overall,
B. A. Brown, and R. J. Wallace, Jr.
1992.
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer.
Clin. Infect. Dis.
14:200-203[Medline].
|
| 25.
|
Springer, B.,
W. K. Wu,
T. Bodmer,
G. Haase,
G. E. Pfyffer,
R. M. Kroppenstedt,
K. H. Schroder,
S. Emler,
J. O. Kilburn,
P. Kirschner,
A. Telenti,
M. B. Coyle, and E. C. Bottger.
1996.
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov.
J. Clin. Microbiol.
34:1100-1107[Abstract].
|
| 26.
|
Stackebrandt, E., and B. M. Goebel.
1994.
Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology.
Int. J. Syst. Bacteriol.
44:846-849[Abstract/Free Full Text].
|
| 27.
|
Steinhaus, E.
1941.
A study of the bacteria associated with thirty species of insects.
J. Bacteriol.
42:757-790[Free Full Text].
|
| 28.
|
Thierry, D.,
V. Vincent,
F. Clement, and J. L. Guesdon.
1993.
Isolation of specific DNA fragments of Mycobacterium avium and their possible use in diagnosis.
J. Clin. Microbiol.
31:1048-1054[Abstract/Free Full Text].
|
| 29.
|
Thompson, J. D.,
T. J. Gibson,
F. Plewniak,
F. Jeanmougin, and D. G. Higgins.
1997.
The CLUSTAL_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
Nucleic Acids Res.
25:4876-82[Abstract/Free Full Text].
|
| 30.
|
Tsukamura, M.,
K. Hikosaka,
K. Nishimura, and S. Hara.
1988.
Severe progressive subcutaneous abscesses and necrotizing tenosynovitis caused by Rhodococcus aurantiacus.
J. Clin. Microbiol.
26:201-205[Abstract/Free Full Text].
|
| 31.
|
Tsukamura, M., and Y. Ikuya.
1985.
Rhodococcus sputi sp. nov., nom. rev., and Rhodococcus aurantiacus sp. nov., nom. rev.
Int. J. Syst. Bacteriol.
35:364-368[Abstract/Free Full Text].
|
| 32.
|
Tsukamura, M., and K. Kawakami.
1982.
Lung infection caused by Gordona aurantiaca (Rhodococcus aurantiacus).
J. Clin. Microbiol.
16:604-607[Abstract/Free Full Text].
|
| 33.
|
Tsukamura, M., and S. Mizuno.
1971.
A new species Gordona aurantiaca occurring in sputa of patients with pulmonary disease.
Kekkaku
46:93-98[Medline]. (In Japanese.)
|
| 34.
|
Yassin, A. F.,
F. A. Rainey,
H. Brzezinka,
J. Burghardt,
H. J. Lee, and K. P. Schaal.
1995.
Tsukamurella inchonensis sp. nov.
Int. J. Syst. Bacteriol.
45:522-527[Abstract/Free Full Text].
|
| 35.
|
Yassin, A. F.,
F. A. Rainey,
H. Brzezinka,
J. Burghardt,
M. Rifai,
P. Seifert,
K. Feldmann, and K. P. Schaal.
1996.
Tsukamurella pulmonis sp. nov.
Int. J. Syst. Bacteriol.
46:429-436[Abstract/Free Full Text].
|
| 36.
|
Yassin, A. F.,
F. A. Rainey,
J. Burghardt,
H. Brzezinka,
S. Schmitt,
P. Seifert,
O. Zimmermann,
H. Mauch,
D. Gierth,
I. Lux, and K. P. Schaal.
1997.
Tsukamurella tyrosinosolvens sp. nov.
Int. J. Syst. Bacteriol.
47:607-614[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, April 2001, p. 1467-1476, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1467-1476.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Olson, J. B., Harmody, D. K., Bej, A. K., McCarthy, P. J.
(2007). Tsukamurella spongiae sp. nov., a novel actinomycete isolated from a deep-water marine sponge. Int. J. Syst. Evol. Microbiol.
57: 1478-1481
[Abstract]
[Full Text]
-
Soddell, J. A., Stainsby, F. M., Eales, K. L., Kroppenstedt, R. M., Seviour, R. J., Goodfellow, M.
(2006). Millisia brevis gen. nov., sp. nov., an actinomycete isolated from activated sludge foam.. Int. J. Syst. Evol. Microbiol.
56: 739-744
[Abstract]
[Full Text]
-
Nichols, W. G., Prentice, J., Houze, Y., Carlson, L., Cookson, B. T.
(2005). Fatal Pulmonary Infection Associated with a Novel Organism, "Parastreptomyces abscessus". J. Clin. Microbiol.
43: 5376-5379
[Abstract]
[Full Text]
-
Nam, S.-W., Kim, W., Chun, J., Goodfellow, M.
(2004). Tsukamurella pseudospumae sp. nov., a novel actinomycete isolated from activated sludge foam. Int. J. Syst. Evol. Microbiol.
54: 1209-1212
[Abstract]
[Full Text]
-
Patel, J. B., Wallace, R. J. Jr., Brown-Elliott, B. A., Taylor, T., Imperatrice, C., Leonard, D. G. B., Wilson, R. W., Mann, L., Jost, K. C., Nachamkin, I.
(2004). Sequence-Based Identification of Aerobic Actinomycetes. J. Clin. Microbiol.
42: 2530-2540
[Abstract]
[Full Text]
-
Woo, P. C. Y., Ngan, A. H. Y., Lau, S. K. P., Yuen, K.-Y.
(2003). Tsukamurella Conjunctivitis: a Novel Clinical Syndrome. J. Clin. Microbiol.
41: 3368-3371
[Abstract]
[Full Text]
-
Pottumarthy, S., Limaye, A. P., Prentice, J. L., Houze, Y. B., Swanzy, S. R., Cookson, B. T.
(2003). Nocardia veterana, a New Emerging Pathogen. J. Clin. Microbiol.
41: 1705-1709
[Abstract]
[Full Text]